Arsanis, Inc. Business Finance Contracts & Agreements
68 Contracts & Agreements
- Forbearance Agreements (1 contract)
- Funding Agreements (11)
- Indenture Agreements (1)
- Investor Rights Agreements (2)
- Loan Agreements (9)
- Purchase Agreements (6)
- Registration Rights Agreements (7)
- Release Agreements (1)
- Share Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (4)
- Warrant Agreements (20)
- First Amendment to Second Amended and Restated Loan and Security Agreement, dated as of August 2, 2023, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules... (Filed With SEC on November 9, 2023)
- X4 Pharmaceuticals, Inc. Amended and Restated 2017 Employment Stock Purchase Plan (Filed With SEC on August 10, 2023)
- Registration Rights Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on May 16, 2023)
- Securities Purchase Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on May 16, 2023)
- Form of May 2023 Pre-Funded Warrant (Filed With SEC on May 16, 2023)
- Form of Class C Warrant (Filed With SEC on December 9, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on December 9, 2022)
- Underwriting Agreement, dated December 7, 2022, by and among the Company, Piper Sandler & Co., Stifel, Nicolaus & Company, Incorporated, and Cantor Fitzgerald & Co (Filed With SEC on December 9, 2022)
- Amendment No. 4 to Amended and Restated Loan and Security Agreement, dated as of June 30, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries... (Filed With SEC on July 1, 2022)
- Registration Rights Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto (Filed With SEC on July 1, 2022)
- Securities Purchase Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto (Filed With SEC on July 1, 2022)
- Form of Warrant (Filed With SEC on July 1, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on July 1, 2022)
- Registration Rights Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 3, 2022)
- Securities Purchase Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 3, 2022)
- Amendment No. 3 to Amended and Restated Loan and Security Agreement, dated as of February 9, 2022, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries... (Filed With SEC on February 9, 2022)
- Registration Rights Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on January 14, 2022)
- Purchase Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on January 14, 2022)
- Registration Rights Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on November 5, 2021)
- Securities Purchase Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on November 5, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on November 5, 2021)
- Registration Rights Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 19, 2021)
- Securities Purchase Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 19, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on March 19, 2021)
- Amendment No. 2 to Amended and Restated Loan and Security Agreement, dated as of December 21, 2020, by and among X4 Pharmaceuticals, Inc., each of its Qualified Subsidiaries... (Filed With SEC on December 23, 2020)
- Common Stock Purchase Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 16, 2020)
- Registration Rights Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 16, 2020)
- Resignation Agreement and Release by and between X4 Pharmaceuticals, Inc. and E. Lynne Kelley, M.D., dated March 18, 2020 (Filed With SEC on March 20, 2020)
- Amendment No. 1 to Loan and Security Agreement, dated March 13, 2020, by and between X4 Pharmaceuticals, Inc. and Hercules Capital, Inc (Filed With SEC on March 17, 2020)
- Form of Class B Warrant (Filed With SEC on November 27, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 27, 2019)
- Underwriting Agreement, dated November 26, 2019, by and among the Company, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on November 27, 2019)
- Amended and Restated Loan and Security Agreement, dated as of June 27, 2019, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules Capital, Inc. and Hercules... (Filed With SEC on June 28, 2019)
- Warrant Agreement, dated as of March 18, 2019, by and between the Company and Hercules Capital, Inc (Filed With SEC on May 15, 2019)
- Amended and Restated Warrant Agreement, dated as of March 29, 2019, by and between the Company and Hercules Capital, Inc (Filed With SEC on May 15, 2019)
- Form of Class A Warrant (Filed With SEC on April 15, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on April 15, 2019)
- Underwriting Agreement, dated April 12, 2019, by and among the Company, Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on April 15, 2019)
- Amendment No. 1 to Loan and Security Agreement, dated as of December 11, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc (Filed With SEC on March 13, 2019)
- Loan and Security Agreement, dated as of October 19, 2018, by and between X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) and Hercules Capital, Inc (Filed With SEC on March 13, 2019)
